- Home
- OPXS vs CMMB Comparison
OPXS vs CMMB Comparison
Compare OPXS & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPXS
- CMMB
- Stock Information
- Founded
- OPXS 1987
- CMMB 2004
- Country
- OPXS United States
- CMMB Israel
- Employees
- OPXS N/A
- CMMB N/A
- Industry
- OPXS Electronic Components
- CMMB Biotechnology: Pharmaceutical Preparations
- Sector
- OPXS Technology
- CMMB Health Care
- Exchange
- OPXS Nasdaq
- CMMB Nasdaq
- Market Cap
- OPXS 45.6M
- CMMB 32.2M
- IPO Year
- OPXS N/A
- CMMB N/A
- Fundamental
- Price
- OPXS $5.90
- CMMB $1.71
- Analyst Decision
- OPXS
- CMMB Strong Buy
- Analyst Count
- OPXS 0
- CMMB 2
- Target Price
- OPXS N/A
- CMMB $9.00
- AVG Volume (30 Days)
- OPXS 25.6K
- CMMB 835.3K
- Earning Date
- OPXS 02-10-2025
- CMMB 03-06-2025
- Dividend Yield
- OPXS N/A
- CMMB N/A
- EPS Growth
- OPXS 42.37
- CMMB N/A
- EPS
- OPXS 0.61
- CMMB N/A
- Revenue
- OPXS $35,225,000.00
- CMMB N/A
- Revenue This Year
- OPXS N/A
- CMMB N/A
- Revenue Next Year
- OPXS N/A
- CMMB N/A
- P/E Ratio
- OPXS $9.70
- CMMB N/A
- Revenue Growth
- OPXS 23.22
- CMMB N/A
- 52 Week Low
- OPXS $5.72
- CMMB $0.58
- 52 Week High
- OPXS $10.30
- CMMB $2.55
- Technical
- Relative Strength Index (RSI)
- OPXS 34.39
- CMMB 32.89
- Support Level
- OPXS $5.91
- CMMB $1.66
- Resistance Level
- OPXS $6.20
- CMMB $2.06
- Average True Range (ATR)
- OPXS 0.35
- CMMB 0.16
- MACD
- OPXS -0.03
- CMMB -0.04
- Stochastic Oscillator
- OPXS 15.25
- CMMB 9.43
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.